FLT3 and acute myeloid leukemia: About 20% of all AMLs harbor a FLT3 ITD mutation, but the mutation is more common in AML with t(15;17) and AML with a normal karyotype (cytogenetically normal AML or CN-AML), accounting for approximately 30% of these cases [3,4].